mitochondrial peptide ss 31 CL-targeted small peptide (named SS-31 - SS-31peptidebenefits SS-31 emerges as a promising therapeutic candidate Unlocking Cellular Vitality: The Science Behind Mitochondrial Peptide SS-31

SS-31 Reddit The quest for enhanced cellular health and longevity has led to the investigation of numerous therapeutic avenues作者：MT Sweetwyne·2017·被引用次数：113—SS-31 treatment improved age-related mitochondrial morphology and glomerulosclerosis. Assessment of glomeruli revealed that SS-31 reduced senescence (p16, .... Among these, mitochondrial peptide SS-31 has emerged as a focal point of significant scientific interest. This novel mitochondrial-target therapy peptide, also known by its brand names Elamipretide® and Bendavia®, is a synthetic peptide that improves mitochondrial function. Its unique ability to precisely target mitochondria positions it as a promising agent for addressing a spectrum of conditions linked to cellular energetic dysfunction.

At its core, mitochondrial peptide SS-31 is designed to interact directly with the mitochondria, the powerhouses of our cells.Neuroprotective Benefit: In models of cognitive impairment,SS-31 improves cognitive functionsby promoting mitochondrial and synaptic health and decreasing ... Research indicates that upon entering the body, SS-31 binds with high affinity to cardiolipin, a crucial phospholipid found predominantly in the inner mitochondrial membrane. This specific binding is a key component of its mechanism of action, allowing it to modulate membrane electrostatics and exert its beneficial effects. The peptide's amphipathic nature, characteristic of Szeto-Schiller (SS) peptides, further contributes to its efficacy across a wide array of mitochondrial disorders.SS-31 treatment ameliorates cardiac mitochondrial ...

One of the most well-documented benefits of SS-31 is its potent antioxidant capacity. It has demonstrated remarkable efficacy in reducing elevated levels of reactive oxygen species (ROS), which are often a byproduct of mitochondrial dysfunction. By acting as a mitochondria-targeting antioxidant, SS-31 helps to neutralize these harmful molecules, thereby protecting cellular components from oxidative damage. This ROS scavenging ability is crucial for preventing cellular damage and promoting overall health. Studies have shown that SS-31 can prevent mitochondrial depolarization and reduce islet cell apoptosis, leading to increased islet function.

The therapeutic potential of SS-31 extends to various organ systems and disease states作者：DF Dai·2011·被引用次数：430—Mitochondrial targeted peptide SS-31ameliorates cardiomyopathy resulting from prolonged Ang stimulation as well as Gαq overexpression, suggesting its potential .... In the context of kidney health, mitochondrial-targeted peptide SS-31 has been shown to ameliorate kidney injury. For instance, SS31 protected renal tubulointerstitial injury in diabetic mice by reducing mitochondrial fragmentationSS-31 Peptide | Benefits, Safety & Buying Advice [2026]. Similarly, research has indicated that SS-31 treatment improved age-related mitochondrial morphology and glomerulosclerosis, offering protective benefits to glomerular mitochondria.

Cardiovascular health is another area where SS-31 shows promise. Mitochondrial targeted peptide SS-31 has been found to ameliorate cardiomyopathy resulting from prolonged stimulation, suggesting its potential in treating heart conditions作者：P List—SS-31 is a novel mitochondrial-target therapy peptidethat crosses the blood brain barrier (BBB) and targets the inner mitochondrial membrane (IMM).. Furthermore, studies have explored its role in improving mitochondrial function in the context of heart failure, with the peptide SS-31 currently undergoing clinical trials for such treatments.

Beyond its direct antioxidant and protective effects, SS-31 also influences broader cellular processes作者：S Russo·2024·被引用次数：19—We found that in vivo treatment of Taz KD mice with aCL-targeted small peptide (named SS-31) was able to restore mitochondrial morphology in tafazzin- .... It has been observed to upregulate frataxin expression, a protein vital for mitochondrial iron metabolism, and consequently improves the quality of mitochondria.SS-31 Peptide | Cellular Energy & Repair This has implications for the treatment of conditions like Friedreich's ataxia.作者：MT Sweetwyne·2017·被引用次数：113—A short course ofSS-31has protective benefits on glomerular mitochondria, accompanied by temporal changes to the glomerular architecture. Moreover, SS-31 has been implicated in neuroprotection. In models of cognitive impairment, SS-31 improves cognitive functions by promoting mitochondrial and synaptic health and decreasing neurodegeneration.Neuroprotective Benefit: In models of cognitive impairment,SS-31 improves cognitive functionsby promoting mitochondrial and synaptic health and decreasing ... It emerges as a promising therapeutic candidate to attenuate neurodegeneration pertinent to alpha-synuclein misfolding and aggregation.

The impact of SS-31 on cellular energy production is also noteworthy作者：MT Sweetwyne·2017·被引用次数：113—A short course ofSS-31has protective benefits on glomerular mitochondria, accompanied by temporal changes to the glomerular architecture.. By improving mitochondrial function, it enhances ATP production, the primary energy currency of the cell, and contributes to overall cellular repair2024年7月11日—SS-31 emerges as a promising therapeutic candidateto attenuate neurodegeneration pertinent to α-synuclein misfolding and aggregation.. This fundamental improvement in cellular energetics makes SS-31 a breakthrough mitochondrial peptide with potential applications in regenerative medicine and addressing age-related cellular decline.

Emerging research also suggests that SS-31 can provide a beneficial effect on macrophages from foam cell formation, likely through both ROS scavenging and inhibition of cholesterol influx. This indicates a role in metabolic health and potentially cardiovascular disease prevention.

While the scientific literature on mitochondrial peptide SS-31 is extensive and growing, it's important to note that much of this research is still in preclinical or early clinical stages. The SS-31 peptide benefits are being actively explored across a range of conditions, and ongoing studies aim to further elucidate its safety and efficacy profile. As research progresses, the full therapeutic potential of this remarkable peptide in enhancing cellular vitality and combating disease becomes increasingly apparent.作者：I Escribano-Lopez·2018·被引用次数：87—Mitochondrial targeting with antioxidant peptide SS-31prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet ...